Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Notable Labs

320 Hatch Drive
Foster City, CA 94404
USA
(703)407-0506
Website Company Summary Management Team
Management

CEO: Thomas A Bock (02/28/2021) ; Matthew De Silva (5/31/2014)
Finance: Christopher Whitmore (10/31/2021)
Technology: Mike Sofen ; Joseph Wagner (12/31/2020)
Business Development: Kevin Lynch
Board

Company

Business description: Notable is a clinical-stage platform therapeutic company developing a new class of precision medicines: predictive precision medicines. Notable aims to be the leader in predictive precision medicine and revolutionize the way in which patients seek and receive treatment: patient population by patient population, and cancer by cancer. By transforming historical standards of care, Notable expects to provide dramatic impact for patients and the healthcare community. Notable’s proprietary Predictive Precision Medicines Platform replicates ex vivo the clinical response of patients to cancer treatments with high fidelity, through its optimized integration of biological assay conditions, dynamic signal analysis, and AI-driven in-silico translation into predictive algorithms. Using its high-fidelity platform, Notable can identify and select clinically responsive patients prior to their treatment and fast-track clinical development in this patient population. Notable has created a targeted, triple de-risked in-licensing strategy and a fast-track clinical development approach that delivers a product’s medical impact and commercial value faster, higher, and more likely than traditional drug development.
Capital

Rounds: 2
Recent Fundings: Jul 2019   Sep 2017
Capital raised: 54.8M
Last Round: 40.0M
Ownership: Private  
Angels/other VCs: Kevin Mahaffey (Lookout)
Other investors: Accelerate Brain Cancer Cure

Last Tweets


 

Last Mentions


Overview
Record updated: Nov 2021
Sector: Medical
Year Founded: 2014
Headcount: 51-75 as of Nov 2021
Rounds: 2
Recent Fundings: Jul 2019   Sep 2017
Capital Raised: 54.8M
Last Round: 40.0M
Ownership: Private